1. Home
  2. Live Updates
  3. Sciwind Biosciences Announces Positive Results from Phase 1

Sciwind Biosciences Announces Positive Results from Phase 1

Sciwind Biosciences Announces Positive Results from Phase 1 Clinical Trial of XW004, an Oral Formulation of Long-acting GLP-1 Analog Ecnoglutide

Sciwind Biosciences Announces Positive Results from Phase 1 Clinical Trial of XW004, an Oral Formulation of Long-acting GLP-1 Analog Ecnoglutide

streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Related Keywords

Australia , Hangzhou , Zhejiang , China , Thai Pan , Sciwind Biosciences , Mohammed Junaidi , Prnewswire Sciwind Biosciences Co Ltd , Clinical Development , Hang Zhou Sciwind Biosciences Co Ltd , Sciwind Vice President ,